Fennec (FENC) Former Director Raykov Rosty Sells 10,000 Shares

What Happened

• Raykov Rosty, a former director of Fennec Pharmaceuticals (FENC), reported two transactions: a release of 2,778 restricted shares (award release) and an open-market sale of 10,000 shares for $12.11 each, generating $121,100. The 2,778 shares were reported at $0.00 (they were released from restriction rather than purchased).

Key Details

• Award release: 2,778 shares on 2026-08-31 at $0.00 (footnote F1: released from shares awarded 5/16/2024).
• Sale: 10,000 shares on 2026-09-01 at $12.11 per share, total proceeds $121,100 (open market sale; footnote F2: sold pursuant to a 10b5-1 plan dated 9/19/2025).
• Shares owned after the reported transactions: not specified in the provided Form 4.
• Filing date/accession: Form 4 filed 2026-09-01 (no indication in the filing of a late report).

Context

• The 2,778-share entry is a release of previously awarded, restricted stock—not a new cash purchase. The sale was executed under a pre-established 10b5-1 trading plan, which generally indicates the sale was preplanned and not an ad hoc decision. As always, sales by insiders can be routine (e.g., tax or diversification) and do not by themselves indicate the insider’s view of the company.